Efficacy of Intravenous Immunoglobulin in Neurological Diseases

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

(2015) Isaak Quast et al.   JOURNAL OF CLINICAL INVESTIGATION

Optimizing IgG therapy in chronic autoimmune neuropathies: A hypothesis driven approach

(2015) Melvin Berger et al.   MUSCLE & NERVE

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

(2015) Jan D. Lünemann et al.   Nature Reviews Neurology

Inhibition of Fc R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc RIIb in human macrophages

(2014) S. Q. Nagelkerke et al.   BLOOD

Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin

(2014) Shivashankar Othy et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo

(2014) Inessa Schwab et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy

(2014) L. H. Markvardsen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Intravenous Immunoglobulin Treatment of the Complex Regional Pain Syndrome

(2013) Andreas Goebel   ANNALS OF INTERNAL MEDICINE

Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy

(2013) Lotte Vlam et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients

(2013) Liene Elsone et al.   Multiple Sclerosis Journal

Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and β-amyloid in the muscle

(2012) Jana Zschüntzsch et al.   ARTHRITIS AND RHEUMATISM

Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fc  receptor for the amelioration of experimental ITP

(2012) D. Leontyev et al.   BLOOD

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review

(2012) Dong Xue Wang et al.   CLINICAL RHEUMATOLOGY

Estudio del efecto del tratamiento con inmunoglobulinas por vía intravenosa en la neuromielitis óptica

(2012) M.J. Magraner et al.   NEUROLOGIA

Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2012) H. S. Patwa et al.   NEUROLOGY

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

(2012) Erwin W. Gelfand   NEW ENGLAND JOURNAL OF MEDICINE

Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin

(2012) Danila Leontyev et al.   TRANSFUSION

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies

(2011) Melvin Berger et al.   CLINICAL IMMUNOLOGY

Choices in IgG replacement therapy for primary immune deficiency diseases

(2011) Melvin Berger   Current Opinion in Allergy and Clinical Immunology

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

(2011) Robert M. Anthony et al.   NATURE

Advances in the diagnosis, pathogenesis and treatment of CIDP

(2011) Marinos C. Dalakas   Nature Reviews Neurology

Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: A national multicentric retrospective study

(2011) Stéphanie Rist et al.   ARTHRITIS CARE & RESEARCH

Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

(2010) Norman Latov   ARCHIVES OF NEUROLOGY

Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy

(2010) Yuichi Kawagashira et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

(2009) Krista Kuitwaard et al.   ANNALS OF NEUROLOGY

Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV

(2009) Vera Bril et al.   MUSCLE & NERVE

Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP

(2009) M. Iijima et al.   NEUROLOGY

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study

(2009) I.S.J. Merkies et al.   NEUROLOGY

Impaired inhibitory Fc  receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

(2009) B. Tackenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

(2008) A. S. De Groot et al.   BLOOD

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis

(2008) Sara Fuchs et al.   JOURNAL OF NEUROIMMUNOLOGY

Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up

(2008) S Jann et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

(2008) Richard AC Hughes et al.   LANCET NEUROLOGY

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: A dose-finding trial

(2008) F. Fazekas et al.   NEUROLOGY

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

(2008) R. M. Anthony et al.   SCIENCE